PRESS DIGEST- Financial Times - March 27
March 27 The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.
Dec 8 Sirona Biochem Corp :
* Sirona Biochem Corp - "expect to receive one or more term sheets from interested parties before end of Q4 2016" for licensing agreement for TFC-1067
* Sirona Biochem Corp - Wanbang Biopharmaceuticals will formulate product (SGLT2 inhibitor) in January 2017 to prepare for a clinical trial
* Sirona Biochem - Wanbang Biopharma will conduct additional pharmacology, toxicology study and file IND package with Chinese FDA for SGLT2 inhibitor
* Sirona Biochem Corp - Valeant is aware of delays in scale-up and has not altered plans to commercialize skin lightener, TFC-849 Source text for Eikon: Further company coverage:
HONG KONG, March 27 Asian stocks are set to start the week on a cautious note as President Donald Trump's stunning failure to get healthcare reform passed raised concerns about the prospects for his plans to use fiscal stimulus to boost economic growth.
March 27 The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy.